To complement excellence in scientific research, successful commercialisation requires research teams to have a strong understanding of their target markets, the specific problems their technologies address, the competitive landscape, and the ability to...
VisOxE for Radiotherapy Enhancement
Tumour hypoxia (lack of oxygen) is an important factor limiting the response to Radiotherapy, with up to 50%-60% of solid tumours being hypoxic. The aim of this project...
Lead: Prof. Helena Kelly, Prof. Stephen Maher
